Chao-Yu Miao

Prof. Dr. Chao-Yu Miao

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Progress in Neurobiology
Verified
Journal Article
Closed access
PWPei Wang
Pei Wang
BSBo-Zong Shao
Bo-Zong Shao
ZDZhiqiang Deng
Zhiqiang Deng
SCShi Chen
Shi Chen
ZYZhenyu Yue
Zhenyu Yue
CMChao-Yu Miao
Chao-Yu Miao

1 January 2012 in Autophagy
Verified
Journal Article
Closed access
PDF file
PWPei Wang
Pei Wang
YGYun-Feng Guan
Yun-Feng Guan
HDHui Du
Hui Du
Qiwei ZhaiQiwei Zhai
Qiwei Zhai
DSDing-Feng Su
Ding-Feng Su
CMChao-Yu Miao
Chao-Yu Miao
Recent reports indicate that autophagy serves as a stress response and may participate in pathophysiology of cerebral ischemia. Nicotinamide phosphoribosyltransferase (Nampt, also known as visfatin), the rate-limiting enzyme in mammalian NAD+ biosynthesis, protects against ischemic stroke through inhibiting neuronal apoptosis and necrosis. This study was taken to determine the involvement of autophagy in neuroprotection of Nampt in cerebral ischemia. Middle cerebral artery occlusion (MCAO) in rats and oxygen-glucose deprivation (OGD) in cultured cortical neurons were performed. Nampt was overexpressed or knocked-down using lentivirus-mediated gene transfer in vivo and in vitro. Immunochemistry (LC3-II), electron microscope and immunoblotting assays (LC3-II, beclin-1, mammalian target of rapamycin [mTOR], S6K1 and tuberous sclerosis complex-2 [TSC2]) were performed to assess autophagy. We found that overexpression of Nampt increased autophagy (LC3 puncta immunochemistry staining, LC3-II/beclin-1 expression and autophagosomes number) both in vivo and in vitro at 2 hours after MCAO. At the early stage of OGD, autophagy inducer rapamycin protected against neuronal injury induced by Nampt knockdown, whereas autophagy inhibitor 3-methyladenine abolished the neuroprotective effect of Nampt partly. Overexpression or knockdown of Nampt regulated the phosphorylation of mTOR and S6K1 signaling pathway upon OGD stress through enhancing phosphorylation of TSC2 at Ser1387 but not Thr1462 site. Furthermore, in cultured SIRT1-knockout neurons, the regulation of Nampt on autophagic proteins LC3-II and beclin-1 was abolished. Our results demonstrate that Nampt promotes neuronal survival through inducing autophagy via regulating TSC2-mTOR-S6K1 signaling pathway in a SIRT1-dependent manner during cerebral ischemia.

24 October 2008 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
PWPei Wang
Pei Wang
TXTian-Ying Xu
Tian-Ying Xu
YGYun-Feng Guan
Yun-Feng Guan
DSDing-Feng Su
Ding-Feng Su
GFGuo-Rong Fan
Guo-Rong Fan
CMChao-Yu Miao
Chao-Yu Miao
Perivascular adipose tissue (PVAT) inhibits vascular smooth muscle cell (VSMC) contraction and stimulates VSMC proliferation by releasing protein factors. The present study was to determine whether visfatin is involved in these paracrine actions of PVAT, and if so, to explore the underlying mechanisms. Visfatin was preferentially expressed in Sprague–Dawley rat and monkey aortic PVAT, compared with subcutaneous and visceral adipose tissues. The PVAT-derived visfatin was found to be a VSMC growth factor rather than a VSMC relaxing factor, which was proved by visfatin-specific antibody/inhibitor and direct observation of recombinant visfatin. Exogenous visfatin stimulated VSMC proliferation in a dose- and time-dependent manner via extracellular signal-regulated kinase (ERK 1/2) and p38 signalling pathways. This proliferative effect was further confirmed by enhancement of DNA synthesis and upregulation of proliferative marker Ki-67. Visfatin had no anti-apoptotic effect on normal cultured VSMCs, and it exerted an anti-apoptotic effect only during cell apoptosis induced by H2O2, excluding a role of anti-apoptosis in the visfatin-induced VSMC proliferation. Insulin receptor knockdown did not show any action on the visfatin effect. However, visfatin acted as a nicotinamide phosphoribosyltransferase to biosynthesize nicotinamide mononucleotide (NMN), which mediated proliferative signalling pathways and cell proliferation similar to the visfatin effect. Visfatin stimulates VSMC proliferation via NMN-mediated ERK1/2 and p38 signalling. The present study provides a molecular link of visfatin to the paracrine action of PVAT, demonstrates a novel function of visfatin in promoting VSMC proliferation, and reveals NMN as a novel signalling molecule that triggers the proliferative process.

19 January 2011 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
PWPei Wang
Pei Wang
TXTian‐Ying Xu
Tian‐Ying Xu
YGYun‐Feng Guan
Yun‐Feng Guan
WTWei‐Wei Tian
Wei‐Wei Tian
Benoit ViolletBenoit Viollet
Benoit Viollet
CMChao-Yu Miao
Chao-Yu Miao

27 June 2016 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
CZCan‐Can Zhou
Can‐Can Zhou
XYXi Yang
Xi Yang
XHXia Hua
Xia Hua
JLJian Liu
Jian Liu
MFMao‐Bing Fan
Mao‐Bing Fan
CMChao-Yu Miao
Chao-Yu Miao

25 August 2015 in Diabetes
Verified
Journal Article
Open access
PDF file
ZLZhi-Yong Li
Zhi-Yong Li
JSJie Song
Jie Song
SZSi-Li Zheng
Si-Li Zheng
MFMao-Bing Fan
Mao-Bing Fan
YGYun-Feng Guan
Yun-Feng Guan
CMChao-Yu Miao
Chao-Yu Miao
Adipokines play important roles in metabolic homeostasis and disease. We have recently identified a novel adipokine Metrnl, also known as Subfatin, for its high expression in subcutaneous fat. Here, we demonstrate a prodifferentiation action of Metrnl in white adipocytes. Adipocyte-specific knockout of Metrnl exacerbates insulin resistance induced by high-fat diet (HFD), whereas adipocyte-specific transgenic overexpression of Metrnl prevents insulin resistance induced by HFD or leptin deletion. Body weight and adipose content are not changed by adipocyte Metrnl. Consistently, no correlation is found between serum Metrnl level and BMI in humans. Metrnl promotes white adipocyte differentiation, expandability, and lipid metabolism and inhibits adipose inflammation to form functional fat, which contributes to its activity against insulin resistance. The insulin sensitization of Metrnl is blocked by PPARγ inhibitors or knockdown. However, Metrnl does not drive white adipose browning. Acute intravenous injection of recombinant Metrnl has no hypoglycemic effect, and 1-week intravenous administration of Metrnl is unable to rescue insulin resistance exacerbated by adipocyte Metrnl deficiency. Our results suggest adipocyte Metrnl controls insulin sensitivity at least via its local autocrine/paracrine action through the PPARγ pathway. Adipocyte Metrnl is an inherent insulin sensitizer and may become a therapeutic target for insulin resistance.